Eva A. Hurst
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Eva A. Hurst has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
M. Laurin Council
Division of Dermatology, Washington University School of Medicine, St. Louis, MO, United States
2 shared publications- Esther Chung
Division of Dermatology, Washington University, St. Louis School of Medicine, St. Louis, Missouri, USA
1 shared publication Ilana Rosman
Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri
1 shared publicationKarl W. Staser
Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri
1 shared publication- Kathleen M. Nemer
Laser and Dermatologic Surgery Center, St. Louis, Missouri
1 shared publication Rachel L. Kyllo
Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri
1 shared publication
Latest Publications
- 1 May 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (5) , e55-e60
Cells to Surgery Quiz: May 2020
- 1 May 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (5) , e55-e60
Cells to Surgery Quiz: May 2020
- 1 January 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (1) , e7-e11
Cells to Surgery Quiz: January 2020
- 1 January 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (1) , e7-e11
Cells to Surgery Quiz: January 2020
- Open Access
- 7 November 2019
- Published by Wolters Kluwer Health in International Journal of Women's Dermatology
- Vol. 6 (2) , 99-101
Surveyed dermatologists are less likely to curette invasive squamous cell carcinoma in solid organ transplant recipients
Background: The risk of squamous cell carcinoma (SCC) is increased in solid organ transplant recipients (OTRs), and preferential treatment modalities vary among clinicians. Objectives: The purpose of this study was to survey dermatologists regarding practice patterns for electrodesiccation and curettage (EDC) of SCC in OTRs and nontransplant patients. Methods: An 18-question survey was sent to dermatologist members of the International Transplant Skin Cancer Collaborative, Association of Professors of Dermatology, and American College of Mohs Surgery. Differences in EDC practice patterns for treatment of SCC in OTRs and nontransplant patients were evaluated. Results: Dermatologists in this study (N = 227) were more likely to treat SCC with EDC in nontransplant patients (67.4%) than in OTRs (48.0%; P = .0003). Dermatologists who perform EDC in both groups (n = 108) were unlikely to use EDC on the H-zone of the face; they were more likely to EDC tumors on non-H-zone areas of the face and neck in nontransplant patients compared to OTRs (P = .0007). Dermatologists were more likely to use EDC over surgery in nontransplant patients compared to OTRs with the following demographics: dementia or psychiatric disease (P = .04), multiple medical comorbidities (P = .03), or anticoagulation medications (P = .02). Conclusions: In OTRs with SCC, 48% of clinicians would consider EDC. The main factors that affect the decision to perform EDC include tumor location and patient comorbidities.
- 7 November 2019
- Published by Wolters Kluwer Health in International Journal of Women's Dermatology
- Vol. 6 (2) , 99-101
Open AccessSurveyed dermatologists are less likely to curette invasive squamous cell carcinoma in solid organ transplant recipients
Background: The risk of squamous cell carcinoma (SCC) is increased in solid organ transplant recipients (OTRs), and preferential treatment modalities vary among clinicians. Objectives: The purpose of this study was to survey dermatologists regarding practice patterns for electrodesiccation and curettage (EDC) of SCC in OTRs and nontransplant patients. Methods: An 18-question survey was sent to dermatologist members of the International Transplant Skin Cancer Collaborative, Association of Professors of Dermatology, and American College of Mohs Surgery. Differences in EDC practice patterns for treatment of SCC in OTRs and nontransplant patients were evaluated. Results: Dermatologists in this study (N = 227) were more likely to treat SCC with EDC in nontransplant patients (67.4%) than in OTRs (48.0%; P = .0003). Dermatologists who perform EDC in both groups (n = 108) were unlikely to use EDC on the H-zone of the face; they were more likely to EDC tumors on non-H-zone areas of the face and neck in nontransplant patients compared to OTRs (P = .0007). Dermatologists were more likely to use EDC over surgery in nontransplant patients compared to OTRs with the following demographics: dementia or psychiatric disease (P = .04), multiple medical comorbidities (P = .03), or anticoagulation medications (P = .02). Conclusions: In OTRs with SCC, 48% of clinicians would consider EDC. The main factors that affect the decision to perform EDC include tumor location and patient comorbidities.
- 1 September 2019
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 139 (9) , e103-e107
Cells to Surgery Quiz: September 2019
- 1 September 2019
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 139 (9) , e103-e107
Cells to Surgery Quiz: September 2019
- 1 August 2019
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 81 (2) , 541-547
Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review
- 1 August 2019
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 81 (2) , 541-547
Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review